A Randomized, Double-blind, Double-dummy, Placebo-controlled Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Sep 2017
At a glance
- Drugs Amiodarone (Primary)
- Indications Arrhythmias; Heart failure
- Focus Therapeutic Use
- Sponsors Prism Pharmaceuticals
- 15 Oct 2009 Results have been published in the American Journal of Cardiology.
- 16 Jan 2008 Status change from recruiting to completed.
- 11 Aug 2007 New trial record.